Bausch + Lomb Corporation

NYSE (USD): Bausch + Lomb Corporation (BLCO)

Last Price

18.00

Today's Change

+0.05 (0.27%)

Day's Change

17.85 - 18.20

Trading Volume

393,257

Overview

Market Cap

6 Billion

Shares Outstanding

352 Million

Avg Volume

556,860

Avg Price (50 Days)

19.82

Avg Price (200 Days)

16.94

PE Ratio

-17.31

EPS

-1.04

Earnings Announcement

19-Feb-2025

Previous Close

17.95

Open

17.85

Day's Range

17.85 - 18.195

Year Range

13.16 - 21.69

Trading Volume

399,560

Price Change Highlight

1 Day Change

0.28%

5 Day Change

-2.33%

1 Month Change

-9.14%

3 Month Change

-9.82%

6 Month Change

20.56%

Ytd Change

6.38%

1 Year Change

14.07%

3 Year Change

-10.00%

5 Year Change

-10.00%

10 Year Change

-10.00%

Max Change

-10.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment